ANA. V. Naumov

A. V. Naumov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. V. Naumov has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Anton P. Pereverzev

    FSBEI FPE «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation

    1 shared publication
  • Ekaterina Nailyevna Dudinskaya

    Pirogov Russian National Research Medical University (Pirogov University)

    1 shared publication
  • O. N. Tkacheva

    Российский национальный исследовательский медицинский университет им. Н.И. Пирогова Минздрава России; Российский геронтологический научно-клинический центр, Москва

    1 shared publication
  • Olga Nikolaevna Tkacheva

    Russian Gerontology Clinical Research Center of Pirogov Russian National Research Medical University

    1 shared publication
  • Yu. V. Kotovskaya

    Russian Clinical and Research Center of Gerontology, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

    1 shared publication
  • Yulia S. Onuchina

    Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation (Pirogov University), Russian Gerontological Research and Clinical Center

    1 shared publication

Latest Publications

  • Open Access

    Non-pharmacological Approaches to Treatment of Patients over 60 Years as a Way to Improve Pharmacotherapy Safety and Prevent Polypharmacy

    by A. P. Pereverzev, O. N. Tkacheva, Yu. V. Kotovskaya, Yu. S. Onuchina, E. N. Dudinskaya, A. V. Naumov, Ю. В. Котовская

    The demographic aging of the population of the earth observed in recent years is associated, inter alia, with the advent of new effective and safe medicines. However, the availability of highly effective drugs on the market also has a reverse side — the appearance of adverse drug reactions (ADRs), in particular as a result of drug-drug interactions. The use of non-pharmacological methods of treatment and prevention of diseases seems particularly relevant for patients of the older age group, as it allows not only to reduce the drug burden, to reduce the risk of ADRs but also to improve the patient’s state in case of diseases that have no effective pharmacotherapy and pharmacological prophylaxis. The aim of the study was to systematize and analyze data on non-pharmacological treatment methods in order to increase the safety of pharmacotherapy and prevent polypragmasia in elderly patients by informing health care providers about non-drug methods of correcting significant geriatric problems. The approaches to the correction of some major geriatric problems (delirium, sarcopenia, pain syndrome), including cognitive training, physical activity, diet, frequent reorientation of patients, placement of patients in specially equipped rooms («delirium room») were presented. The use of non-pharmacological approaches can significantly improve the safety of drug therapy, reduce the risks of ADRs, improve the patient’s prognosis and quality of life, and also effectively prevent polypharmacy.


  • Open Access

    What can apply for the role of basic therapy for chronic pain in comorbid patients?

    by A. V. Naumov, O. N. Tkacheva

    Хроническая боль в суставах и спине является практически постоянным компонентом коморбидных состояний. В основе последних лежит синдром системного воспаления, активность которого влияет и на степень развития патологии, опосредующей прогрессирование хронической боли. В структуре патогенеза системного воспаления обращает на себя целый спектр транскрипционных белков, активность которых связана с уровнем синтеза провоспалительных медиаторов. Научные исследования последних лет показали, что недостаточность и дефицит витамина D3 повышают активность указанных транскрипционных белков, увеличивая прогрессирование и интенсивность компонентов коморбидности, включая болевой синдром. Фундаментальные научные исследования демонстрируют противовоспалительный и антиэрозивный эффект витамина D3в хрящевой и костной ткани.